Clinical Trial Update: The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

A Phase 3 trial updating safety and efficacy of rivaroxaban plus ticagrelor in patients with atrial fibrillation after percutaneous coronary intervention for ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Atrial Fibrillation, Acute Coronary Syndrome | Phase 3 | Status: UNKNOWN